2010 to 2021 saw increase in incidence of Stage IV breast cancer2010 to 2021 saw increase in incidence of Stage IV breast cancer
From 2010 to 2021, there was a significant increase in the incidence of stage IV breast cancer, according to a study published online May 12 in JAMA Network Open.
STAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and moreSTAT+: Pharmalittle: We’re reading about an AstraZeneca breast cancer pill, an ADAP deal in Florida, and more
The FDA extended the decision deadline for an experimental breast cancer pill from AstraZeneca after an advisory panel voted against the drug
La American Cancer Society actualiza la Guía de detección del cáncer colorrectal: Los cambios más importantes enfatizan las pruebas basadas en sangre y las pruebas caseras en heces.La American Cancer Society actualiza la Guía de detección del cáncer colorrectal: Los cambios más importantes enfatizan las pruebas basadas en sangre y las pruebas caseras en heces.
Los investigadores de la American Cancer Society (ACS) apuntan a reducir las muertes por cáncer colorrectal ofreciendo opciones para mejorar la participación en las pruebas de detección.
Doctors Are Revealing The GLP-1 Risks People Don’t Talk About Enough, And Wow, We Really Should Discuss ThisDoctors Are Revealing The GLP-1 Risks People Don’t Talk About Enough, And Wow, We Really Should Discuss This
“These medications also come with risks that aren’t as freely talked about as their benefits.” View Entire Post › “These medications also come with risks that aren’t as freely talked about as their benefits.” View Entire Post ›
New First-Line Option Approved in Triple-Negative Breast CancerNew First-Line Option Approved in Triple-Negative Breast Cancer
(MedPage Today) — The FDA on Friday approved datopotamab deruxtecan (Dato-DXd; Datroway) as a first-line option for unresectable or metastatic triple-negative breast cancer patients ineligible for immunotherapy.
Approval of the Trop2-directed…
Blood test detects early signs of breast cancer recurrenceBlood test detects early signs of breast cancer recurrence
Researchers at Lund University have developed a blood test capable of detecting signs of breast cancer recurrence long before recurrence becomes visible on imaging or causes symptoms. It has previously been shown that this method can detect extremely small amounts of tumor DNA in blood samples with very high precision and specificity. In the current much larger study, patients were followed over time to evaluate how accurately the method could predict recurrence and monitor treatment response.
Trump’s Medical Exam; Ebola Outpacing Response; Eating Disorders and GLP-1sTrump’s Medical Exam; Ebola Outpacing Response; Eating Disorders and GLP-1s
(MedPage Today) — Note that some links may require registration or subscription. President Donald Trump is expected to have a medical exam today at Walter Reed National Military Medical Center, marking the third such appointment in 13 months… (MedPage Today) — Note that some links may require registration or subscription. President Donald Trump is Read More
Ozempic-style drugs linked to major slowdown in cancer spread, new study findsOzempic-style drugs linked to major slowdown in cancer spread, new study finds
Popular glucagon-like peptide-1 (GLP-1) weight-loss drugs may help slow the spread of some cancers, according to new research to be presented at a major medical conference. Research led by Cleveland Clinic found that the medications may reduce the spread of several obesity-related cancers, including lung, breast, colorectal and liver cancers. The findings will be presented Read More
FDA approves Enhertu as neoadjuvant, adjuvant treatment for breast cancerFDA approves Enhertu as neoadjuvant, adjuvant treatment for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca’s Enhertu (fam-trastuzumab deruxtecan-nxki) for both the neoadjuvant and adjuvant treatment of patients with human epidermal growth factor receptor 2 (HER2)-positive early breast cancer.
Once-Weekly Semaglutide in Adults With Daily Cigarette UseOnce-Weekly Semaglutide in Adults With Daily Cigarette Use
This randomized clinical trial evaluates the effects of semaglutide vs placebo on cigarette smoking, craving, and weight outcomes in people who smoke. This randomized clinical trial evaluates the effects of semaglutide vs placebo on cigarette smoking, craving, and weight outcomes in people who smoke.